Your account is not claimed yet. You can sign up with ORCID to claim your account.

Caroline B Kurtz (Caroline Kurtz)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Bacillus Subtilis

Placebo Controlled

Top Venues

Nature metabolism

Nature communications

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jerry Vockley, Neal Sondheimer, Marja K Puurunen, George A Diaz, Ilona Ginevic, Dorothy K Grange, Cary O Harding, Hope Northrup, John A Phillips, Shawn Searle, Janet A Thomas, Roberto Zori, William S Denney, Sharon L Ernst, Kristina Humphreys, Nicole McWhorter, Caroline B Kurtz, Aoife M Brennan
Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial. Nature metabolism (2023)
Marja K Puurunen, Jerry Vockley, Shawn L Searle, Stephanie J Sacharow, John A Phillips, William S Denney, Benjamin D Goodlett, David A Wagner, Larry Blankstein, Mary J Castillo, Mark R Charbonneau, Vincent M Isabella, Vasu V Sethuraman, Richard J Riese, Caroline B Kurtz, Aoife M Brennan
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study. Nature metabolism 3 (8) (2021)
Caroline B Kurtz, Yves A Millet, Marja K Puurunen, Mylène Perreault, Mark R Charbonneau, Vincent M Isabella, Jonathan W Kotula, Eugene Antipov, Yossi Dagon, William S Denney, David A Wagner, Kip A West, Andrew J Degar, Aoife M Brennan, Paul F Miller
An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Science translational medicine 11 (475) (2020)
Mark R Charbonneau, Vincent M Isabella, Ning Li, Caroline B Kurtz
Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nature communications 11 (1) (2020)